Repurposing of Miltefosine as an Adjuvant for Influenza Vaccine

Repurposing of Miltefosine as an Adjuvant for Influenza Vaccine

We previously reported that topical imiquimod can improve the immunogenicity of the influenza vaccine. This study investigated another FDA-approved drug, miltefosine (MTF), as a vaccine adjuvant. Mice immunized with an influenza vaccine with or without MTF adjuvant were challenged by a lethal dose o...

Descripció completa

Dades bibliogràfiques
Autors principals: Lu Lu, Carol Ho-Yan Fong, Anna Jinxia Zhang, Wai-Lan Wu, Iris Can Li, Andrew Chak-Yiu Lee, Thrimendra Kaushika Dissanayake, Linlei Chen, Ivan Fan-Ngai Hung, Kwok-Hung Chan, Hin Chu, Kin-Hang Kok, Kwok-Yung Yuen, Kelvin Kai-Wang To
Format: Article
Idioma:English
Publicat: MDPI AG 2020-12-01
Col·lecció:Vaccines
Matèries:
influenza vaccine
vaccine
adjuvant
T<sub>FH</sub>
miltefosine
Accés en línia:https://www.mdpi.com/2076-393X/8/4/754

Internet

https://www.mdpi.com/2076-393X/8/4/754

Ítems similars